Aurinia Pharmaceuticals Inc (AUPH)
5.10
-0.07
(-1.35%)
USD |
NASDAQ |
May 03, 16:00
5.095
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals Cash from Financing (TTM): -5.13M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -5.13M |
September 30, 2023 | 1.135M |
June 30, 2023 | 3.467M |
March 31, 2023 | 3.667M |
December 31, 2022 | 2.433M |
September 30, 2022 | 207.47M |
June 30, 2022 | 216.55M |
March 31, 2022 | 216.49M |
December 31, 2021 | 221.11M |
September 30, 2021 | 16.63M |
June 30, 2021 | 196.81M |
March 31, 2021 | 196.48M |
December 31, 2020 | 194.38M |
September 30, 2020 | 390.05M |
June 30, 2020 | 215.64M |
March 31, 2020 | 215.12M |
December 31, 2019 | 243.85M |
September 30, 2019 | 47.55M |
June 30, 2019 | 32.71M |
March 31, 2019 | 35.66M |
December 31, 2018 | 4.014M |
September 30, 2018 | 3.457M |
June 30, 2018 | 4.692M |
March 31, 2018 | 2.972M |
December 31, 2017 | 175.15M |
Date | Value |
---|---|
September 30, 2017 | 203.64M |
June 30, 2017 | 209.83M |
March 31, 2017 | 214.80M |
December 31, 2016 | 42.62M |
September 30, 2016 | 14.08M |
June 30, 2016 | 6.696M |
March 31, 2016 | 0.47M |
December 31, 2015 | 0.839M |
September 30, 2015 | 1.381M |
June 30, 2015 | 1.802M |
March 31, 2015 | 1.422M |
December 31, 2014 | 47.89M |
September 30, 2014 | 47.34M |
June 30, 2014 | 52.39M |
March 31, 2014 | 53.22M |
December 31, 2013 | 6.375M |
September 30, 2013 | 7.131M |
June 30, 2013 | 1.592M |
March 31, 2013 | 0.7197M |
December 31, 2012 | 0.7167M |
September 30, 2012 | -0.0084M |
June 30, 2012 | -0.1577M |
March 31, 2012 | -0.1386M |
December 31, 2011 | 2.282M |
September 30, 2011 | 2.324M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-5.13M
Minimum
Dec 2023
390.05M
Maximum
Sep 2020
137.71M
Average
196.48M
Median
Mar 2021
Cash from Financing (TTM) Benchmarks
Lexaria Bioscience Corp | 6.862M |
Acasti Pharma Inc | 7.359M |
Edesa Biotech Inc | 2.224M |
Xenon Pharmaceuticals Inc | 353.52M |
ESSA Pharma Inc | 0.1129M |